Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.

@article{Mizuno2008IdentificationOA,
  title={Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.},
  author={Tetsuya Mizuno and Genichiro Ishii and Kanji Nagai and Junji Yoshida and Mitsuyo Nishimura and Takahiro Mochizuki and Osamu Kawai and Takahiro Hasebe and Atsushi Ochiai},
  journal={Lung cancer},
  year={2008},
  volume={62 3},
  pages={302-8}
}
OBJECTIVES Several trials have recently reported the efficacy of adjuvant chemotherapy for resected stage IB non-small cell lung cancer (NSCLC). However, the histological findings and prognosis of stage IB lung adenocarcinoma vary considerably. The aim of this study was to investigate prognostic factors of resected stage IB adenocarcinoma and identify a subgroup with a better prognosis, in which adjuvant chemotherapy could be omitted. METHODS We reviewed 413 cases of stage I lung… CONTINUE READING